Ever Source Wealth Advisors, LLC Theravance Biopharma, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 288 shares of TBPH stock, worth $4,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
288
Previous 42
585.71%
Holding current value
$4,043
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TBPH
# of Institutions
138Shares Held
48.5MCall Options Held
0Put Options Held
11.6K-
Madison Avenue Partners, LP New York, NY9.51MShares$134 Million11.23% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$105 Million1.24% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$69.5 Million10.56% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$53.1 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$38.8 Million4.49% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $938M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...